Top
image credit: Unsplash

Sagent Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Levetiracetam Injection, USP Due to Lack of Sterility Assurance

November 22, 2021

Via: Drugs.com
Category:

November 19, 2021 – Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of four lots of Levetiracetam Injection, USP, to the user level. The lack of container closure integrity, found in reserve sample vials may result in a non-sterile product.

Risk Statement: Intravenous administration of a product intended to be sterile that is not sterile could result in serious systemic infections which may be life threatening. To date, Sagent has not received reports of any product complaints or adverse events associated with this issue.

Read More on Drugs.com